Abstract
Ceramide is a physiologic regulator of growth and differentiation in mammalian cells. In this study, the relationship between ceramide and FLICE inhibitory protein (FLIP) in the induction of apoptosis in glioblastoma cell lines was investigated. We found that LN215 cells were slightly more sensitive to Fas-mediated apoptosis than LN319 cells, which were more sensitive to ceramide than LN215 cells. FLIP was expressed in LN319 and LN215 cells constitutively, and this expression decreased with treatment of ceramide in LN215 cells, which might cause LN215 cells to be more sensitive to Fas-mediated apoptosis at lower level stimulation. In LN319 cells FLIP levels were not modified by ceramide treatment and the level of cell death induced by anti-Fas antibody was not affected. Our results suggest that FLIP may be down-regulated by low levels of ceramide in LN215 cells, which causes LN215 cells to be more sensitive to Fas-mediated apoptosis, whereas LN319 cells remain resistant.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hannun YA: The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269: 3125–3128, 1994
Haimovitz-Friedman A, Kolesnick RN, Fuks Z: Ceramide signaling in apoptosis. Br Med Bull 53: 539–553, 1997
Chao MV: Ceramide: a potential second messenger in the nervous system. Mol Cell Neurosci 6: 91–96, 1995
Kanto T, Kalinski P, Hunter OC, Lotze MT, Amoscato AA: Ceramide mediates tumor-induced dendritic cell apoptosis. J Immunol 167: 3773–3784, 2001
Homaidan FR, Chakroun, Dbaibo GS, El-Assaad W, El-Sabban ME: IL-1 activates two phospholipid signaling pathways in intestinal epithelial cells. Inflamm Res 50: 375–381, 2001
Brann AB, Scott R, Neuberger Y, Abulafia D, Boldin S, Fainzilber M, Futerman AH: Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons. J Neurosci 19: 8199–8206, 1999
Foghi A, Ravandi A, Teerds KJ, van der Donk H, Kuksis A, Dorrington J: Fas-induced apoptosis in rat thecal/interstitial cells signals through sphingomyelin-ceramide pathway. Endocrinology 139: 2041–2047, 1998
Colombaioni L, Frago LM, Varela-Nieto I, Pesi R, Garcia-Gil M: Serum deprivation increases ceramide levels and induces apoptosis in undifferentiated HN9.10e cells. Neurochem Int 40: 327–336, 2002
Claus R, Russwurm S, Meisner M, Kinscherf R, Deigner HP: Modulation of the ceramide level, a novel therapeutic concept? Curr Drug Targets 1: 185–205, 2001
Cifone MG, Migliorati G, Parroni R, Marchetti C, Millimaggi D, Santoni A, Riccardi C: Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93: 2282–2296, 1999
Zhang Y, Mattjus P, Schmid PC, Dong Z, Zhong S, Ma WY, Brown RE, Bode AM, Schmid HH, Dong Z: Involvement of the acid sphingomyelinase pathway in uva-induced apoptosis. J Biol Chem 276: 11775–11782, 2001
Wagenknecht B, Roth W, Gulbins E, Wolburg H, Weller M: C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis. Cell Death Differ 8: 595–602, 2001
Siskind LJ, Colombini M: The lipids C2-and C16-ceramide form large stable channels. Implications for apoptosis. J Biol Chem 275: 38640–38644, 2000
Mikami T, Kashiwagi M, Tsuchihashi K, Akino T, Gasa S: Substrate specificity and some other enzymatic properties of dihydroceramide desaturase (ceramide synthase) in fetal rat skin. J Biochem (Tokyo) 123: 906–911, 1998
Susin SA, Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, Fassy F, Reed JC, Kroemer G: The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J Exp Med 186: 25–37, 1997
Hu S, Vincenz C, Ni J, Gentz R, Dixit VM: I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1-and CD-95-induced apoptosis. J Biol Chem 272: 17255–17257, 1997
Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME: Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274: 22532–22538, 1999
Scaffidi C, Schmitz I, Krammer PH, Peter ME: The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274: 1541–1548, 1999
Tepper CG, Seldin MF: Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma. Blood 94: 1727–1737, 1999
Nam SY, Amoscato AA, Lee YJ: Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway. Oncogene 21: 337–346, 2002
Hsu YT, Youle RJ: Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations.J Biol Chem 273: 10777–10783, 1998
Murphy KM, Streips UN, Lock RB: Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2. Oncogene 18: 5991–5999, 1999
Gross A, McDonnell JM, Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899–1911, 1999
Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B: Role of BAX in the apoptotic response to anticancer agents. Science 290: 989–992, 2000
Perlman H, Zhang X, Chen MW, Walsh K, Buttyan R: An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death Differ 6: 48–54, 1999.fs
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoon, G., Kim, KO., Lee, J. et al. Ceramide Increases Fas-mediated Apoptosis in Glioblastoma Cells through FLIP Down-regulation. J Neurooncol 60, 135–141 (2002). https://doi.org/10.1023/A:1020604705831
Issue Date:
DOI: https://doi.org/10.1023/A:1020604705831